Search

Why and what should hearing care professionals know about cognitive impairment and dementia

Good reasons to care about cognitive impairment and dementia in audiology If asking people what they fear most when getting to old age, it is cognitive decline that is named most often. This comes with the expectation of limitations in...

The outer ear in the visual arts

The ear is an exceptional organ, and quite rightly takes its place in the visual arts, as described by Albert Mudry, who takes us on a whistle-stop tour of the appearance of the ear and its depictions in art throughout...

The effects of polypharmacy in the elderly

Another pill to cure the ill? Alec Lapira discusses the warning signs of polypharmacy in the elderly population. Polypharmacy in the elderly Polypharmacy – defined as the use of five or more medications – occurs in 20–37% of older people...

In conversation with Sam Lear, BAA President: leading audiology forward

Dr Samantha Lear is the current British Academy of Audiology President, and Senior Audiology Policy Advisor at the National Deaf Children’s Society. With reviews ongoing in paediatric audiology in England and Scotland, Sam is ideally placed to lead the profession....

Commentary: dementia, hearing loss, and the danger of professional rabbit holes

The Lancet, a world-leading general medical journal, has a global impact. Its commissioned report into dementia prevention, intervention and care has been cited over 6000 times and has further been reviewed and updated in 2020 and now 2024. Here, Profs...

Barriers to cochlear implantation in low resource settings

The benefits of early detection and rehabilitation of hearing loss in children, especially through cochlear implantation, are unequivocal. However, access to these valuable resources is far from equal and universal. Identifying the barriers is the first major step in addressing...

Wisdom and the cochlear implant clinician

Helen Cullington provides the clinician’s perspective on the challenges faced in building artificial intelligence into cochlear implant clinics. She highlights the importance of including the clinician with their wisdom and experience to help make sense of the patterns of data....

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...